Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!
CytoSolv is developing wound-healing technology derived from porcine choroid plexus.
Headlines from Mass High Tech about CYTOSOLV INC
Print this Listing
| Industry Classification | Biopharma/Biotechnology |
| Primary Business Focus | Biotechnology - Pharmaceutical |
| Year Established | 2009 |
| Ownership Type | Private |
| Moses Goddard | CEO | |||
| Christopher Thanos | VP R&D | email available to subscribers | ||
| Briannan Bintz | Bioengineer |
* Downloads will not contain Personnel E-mail addresses
| Focus | Biotechnology - Pharmaceutical |
| Location | Providence, RI |
| Website | http://www.cytosolv.com |
| Revenue | Subscriber access only |
| Address | 117 Chapman St Suite 107 Providence, RI, 02905 |
| Phone | 401-228-6088 |
| Subscriber access only | |
| Website | www.cytosolv.com |
© 2012 American City Business Journals. All rights reserved. Use of this Site constitutes acceptance of our User Agreement (updated 3/14/12) and Privacy Policy (updated 3/14/12).
Your California Privacy Rights.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of American City Business Journals.